Anticoagulants vs thrombolytic therapy for the management of right heart thrombus in pulmonary embolism: A systematic review

Figure 1 Study selection algorithm.

Figure 2 Risk of bias assessment in prognostic studies using the Quality In Prognosis Studies tool.

Figure 3 Results of the meta-analysis of odds ratios. A: For all-cause mortality in patients with right heart thrombi (RHT) and pulmonary embolism (PE); B: For 30-day all-cause mortality in patients with RHT and PE. Red squares represent the weight of each individual study (the size of the squares corresponds to the study weight); black lines represent the 95%CI; the black diamond represents the pooled odds ratio.